Evidence map›Paper›PMID 42845477›Full record

ArticlebioRxiv : the preprint server for biology2026

SAMP V2: A novel stacking ensemble learning model for antimicrobial peptides identification based on augmented split amino acid composition with biochemical-sequence-order information.

Mengtao Sun, Jieqiong Wang, Shibiao Wan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mengtao SunDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
Jieqiong WangDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Shibiao WanDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0003-0661-2684

Funding

Unveiling Adolescent BNST Development with Deep Learning: Implications for Alcohol Use and Negative AffectR21AA032098 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer Urbano Blackford, Shibiao Wan · 2026 to 2026
$403k
Leveraging Heterogenous Common Fund Data Sets and Beyond for Identifying Lung Cancer SubtypesR03OD038391 · OD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WAN, SHIBIAO, WANG, JIEQIONG · 2024 to 2024
$307k
NIAAA NIH HHS R21 AA032098NIH HHS R03 OD038391
6 · The paper itself

Abstract

Antimicrobial resistance reduces the effectiveness of conventional antibiotics and has become a major global health threat, highlighting the need for new anti-infective agents. Antimicrobial peptides (AMPs), a diverse class of innate immune effectors with broad-spectrum antimicrobial activity, are promising candidates for combating drug-resistant infections. Identifying AMPs by wet-lab experiments, however, remains costly and time-consuming, creating a strong demand for computational identification methods. Our recently developed method, SAMP, captures region-specific residue distributions based on proportionalized split amino acid composition. However, SAMP might ignore key biochemical information and sequence order information. Here we present SAMP V2, a stacking ensemble learning framework based on biochemical and sequence-order information augmented split amino acid composition (BIA-SAAC), which extends SAMP by integrating pseudo-amino acid composition features with biochemical and sequence-order information into split peptide regions. Specifically, each peptide is divided into N-terminal, middle, and C-terminal regions, and pseudo amino acid composition is calculated within each region. Benchmarking tests on six independent test datasets, SAMP V2 outperformed multiple state-of-the-art models, including AMPpred-MFA and iAMP-Attenpred, in terms of accuracy, MCC, G-measure and F1-score. Given its high and robust performance, SAMP V2 could significantly accelerate the discovery of next-generation antimicrobial therapeutics for addressing the global threat of multidrug-resistant pathogens.

Indexed as

Antimicrobial peptidesBiochemical-information augmented split amino acid compositionSAMP V2Stacking ensemble learning

Identifiers

PMID42845477
PMCPMC13640695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.